Diabetes

Study finds link between marital bliss and greater risk of diabetes development.

Linagliptin and metformin hydrochloride extended-release (Jentadueto XR) tablets approved for type 2 diabetes.

Linagliptin and metformin hydrochloride extended-release tablets approved for adults with type 2 diabetes.

The burden of repeated insulin injections is often cited as a factor of resistance to starting traditional insulin products.

The FDA has issued new guidance for the use of the first-line diabetes drug metformin in patients with renal impairment.

The FDA has approved linagliptin and metformin hydrochloride extended-release (Jentadueto XR) tablets for adults with type 2 diabetes.

Because diabetes can affect many parts of the body, there's a lot to remember for self-management.

Treatment delays prevent tight blood sugar control in type 2 diabetes patients.

Vegetative area levels linked to significant decreases in diabetes, chronic illnesses, high cholesterol, and hypertension.

Lixisenatide is an investigational fixed-ratio combination of basal insulin glargine 100 Units/mL and GLP-1 receptor agonist for adults with type 2 diabetes.

Acute exenatide administration reduces glucose production and insulin resistance in liver tissue.

Important health screenings for patients taking antipsychotic medication are not being carried out in certain patient groups.

Patients who develop foot ulcers and necrosis as a result of their diabetes may be at risk of experiencing significant cognitive declination.

Potential risk of leg and foot amputations associated with the use of the diabetes medication canagliflozin.

Pharmacists can have a positive influence on medication adherence and several other factors in type 2 diabetes.

Diabetes drug interactions may decrease medication efficacy, increase toxicity, challenge adherence, and cause adverse events.

Patients with diabetes have a higher pill burden than the general population, so pharmacists should pay particular attention to potential drug interactions with antidiabetic agents.

Dendritic cell-based therapy shows promise treating diabetic peripheral neuropathy and ulcerations in the cornea and skin.

As melatonin levels rise, beta cells are prompted to release less insulin.

Diabetes in pregnant women may be associated with a lower supply of breast milk.

This article highlights several key therapeutics areas for insulin degludec that every pharmacist should know.

About 60% of patients with diabetes worldwide are Asian.

Pharmacists should double-check that patients with diabetes are vaccinated against hepatitis B, pneumococcal disease, and influenza.

Screening for vitamin D levels vital when treating adolescents with diabetes.

Incretin-based drugs help type 2 diabetes patients reduce blood sugar.